Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Sorlandet Hospital HF | OTHER_GOV |
| Norwegian Institute of Public Health | OTHER_GOV |
| London School of Hygiene and Tropical Medicine | OTHER |
| Leiden University |
Not provided
Not provided
Not provided
Not provided
Through SARS-CoV-2 IgG testing of PCR positive and negative cases the study will follow the COVID-19 immune response by monitoring the SARS-CoV-2 IgG antibody levels over a period of two years. Further, risk factors will be identified by the use of the test-negative design including population controls, allowing comparison of participants with positive and negative tests, and with population controls (triangulation). Special emphasis will be on high risk groups in general and on different occupational, environmental and socio-economic groups in particular. Finally, severity of illness, deaths and the use of health care during will be assessed using national register data from Telemark and Agder.
Objectives
The main objectives are:
The main exposures are (WP1-3):
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| SARS-CoV-2 PCR positive cases | Antibody tests will be performed every 6 months for 2 years | ||
| SARS-CoV-2 PCR negative cases | Antibody tests will be performed at baseline | ||
| Population controls | A large sample (n= 22500) from the general population will be included to assess risk factors. No blood sample will be collected for this group and the data needed is already collected. |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| SARS-CoV-2 IgG antibody level | Serum Levels of SARS-CoV-2 IgG antibody and the Development of these over a two years period | 2020-2023 |
| Risk factors for COVID-19 | Different risk factors (age, sex, education, comorbidity, occupational and environmental exposure will be assessed | 2020-2026 |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Inhabitants of Agder and Telemark County in Norway fulfilling the inclusion criteria.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Anne Kristin M. Fell, PhD | Sykehuset Telemark | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Telemark Hospital | Skien | Vestfold and Telemark | 3710 | Norway |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 40462062 | Derived | Sarjomaa M, Berg KK, Jaioun K, Tveten Y, Kersten H, Reiso H, Eikeland R, Thilesen C, Nordbo SA, Aaberge IS, Pearce N, Fell AKM. SARS-CoV-2-specific humoral immunity in a Norwegian cohort between 2020 and 2023. BMC Med. 2025 Jun 3;23(1):332. doi: 10.1186/s12916-025-04171-2. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000086382 | COVID-19 |
| ID | Term |
|---|---|
| D011024 | Pneumonia, Viral |
| D011014 | Pneumonia |
| D012141 | Respiratory Tract Infections |
| D007239 | Infections |
Not provided
Not provided
| OTHER |
| Aalborg University | OTHER |
Not provided
Not provided
Not provided
Serum samples for SARS-CoV-2 IgG antibody testing
| D014777 |
| Virus Diseases |
| D018352 | Coronavirus Infections |
| D003333 | Coronaviridae Infections |
| D030341 | Nidovirales Infections |
| D012327 | RNA Virus Infections |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |